Unexpected mobilisation of lead during cisplatin chemotherapy.
During an investigation by X-ray fluorescence of platinum uptake in the kidney after chemotherapy with cisplatin, lead was found to have accumulated in the kidney in four subjects. The average kidney lead burden in one case exceeded 800 micrograms/g. Although two of the subjects had been occupationally exposed to lead, the other two had not. The tibia lead burden was also high in the two subjects in whom it was measured. The origins of this mobilised lead and the implications for cisplatin nephrotoxicity are discussed.
D000368:Aged; D001822:Body Burden; D001842:Bone and Bones / Q000378:metabolism; D002945:Cisplatin / Q000009:adverse effects* / Q000378:metabolism; D004781:Environmental Exposure; D005260:Female; D006801:Humans; D007668:Kidney / Q000378:metabolism; D007854:Lead / Q000378:metabolism*; D008297:Male; D008875:Middle Aged; D010865:Pilot Projects; D010984:Platinum / Q000378:metabolism
D007854:Lead; D010984:Platinum; D002945:Cisplatin